COLOPLAST NAM. B DK 1COLOPLAST NAM. B DK 1COLOPLAST NAM. B DK 1

COLOPLAST NAM. B DK 1

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪23.98 B‬EUR
3.05EUR
‪677.13 M‬EUR
‪3.62 B‬EUR
‪142.07 M‬
Beta (1Y)
0.34
Employees (FY)
‪16.64 K‬
Change (1Y)
+947 +6.03%
Revenue / Employee (1Y)
‪217.74 K‬EUR
Net income / Employee (1Y)
‪40.70 K‬EUR

About COLOPLAST B A/S


CEO
Kristian Villumsen
Headquarters
Humlebaek
Founded
1957
ISIN
DK0060448595
FIGI
BBG000BRKJL0
Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
C
XS248128852
COLOPL. FIN. 22/30 MTN
Yield to maturity
3.21%
Maturity date
May 19, 2030
C
XS248128780
COLOPL. FIN. 22/27 MTN
Yield to maturity
2.71%
Maturity date
May 19, 2027

Explore more bonds 

Frequently Asked Questions


The current price of CBHD is 106.70 EUR — it has decreased by −0.28% in the past 24 hours. Watch COLOPLAST NAM. B DK 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange COLOPLAST NAM. B DK 1 stocks are traded under the ticker CBHD.
CBHD stock has fallen by −3.13% compared to the previous week, the month change is a −10.67% fall, over the last year COLOPLAST NAM. B DK 1 has showed a 4.97% increase.
We've gathered analysts' opinions on COLOPLAST NAM. B DK 1 future price: according to them, CBHD price has a max estimate of 137.62 EUR and a min estimate of 93.53 EUR. Watch CBHD chart and read a more detailed COLOPLAST NAM. B DK 1 stock forecast: see what analysts think of COLOPLAST NAM. B DK 1 and suggest that you do with its stocks.
CBHD reached its all-time high on Nov 22, 2021 with the price of 159.70 EUR, and its all-time low was 36.95 EUR and was reached on Dec 27, 2012. View more price dynamics on CBHD chart.
See other stocks reaching their highest and lowest prices.
CBHD stock is 0.28% volatile and has beta coefficient of 0.34. Track COLOPLAST NAM. B DK 1 stock price on the chart and check out the list of the most volatile stocks — is COLOPLAST NAM. B DK 1 there?
Today COLOPLAST NAM. B DK 1 has the market capitalization of ‪24.01 B‬, it has decreased by −2.92% over the last week.
Yes, you can track COLOPLAST NAM. B DK 1 financials in yearly and quarterly reports right on TradingView.
COLOPLAST NAM. B DK 1 is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CBHD earnings for the last quarter are 0.73 EUR per share, whereas the estimation was 0.77 EUR resulting in a −5.06% surprise. The estimated earnings for the next quarter are 0.79 EUR per share. See more details about COLOPLAST NAM. B DK 1 earnings.
COLOPLAST NAM. B DK 1 revenue for the last quarter amounts to ‪931.93 M‬ EUR, despite the estimated figure of ‪921.87 M‬ EUR. In the next quarter, revenue is expected to reach ‪939.02 M‬ EUR.
CBHD net income for the last quarter is ‪176.12 M‬ EUR, while the quarter before that showed ‪170.44 M‬ EUR of net income which accounts for 3.33% change. Track more COLOPLAST NAM. B DK 1 financial stats to get the full picture.
COLOPLAST NAM. B DK 1 dividend yield was 2.51% in 2024, and payout ratio reached 97.94%. The year before the numbers were 2.81% and 94.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪16.64 K‬ employees. See our rating of the largest employees — is COLOPLAST NAM. B DK 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COLOPLAST NAM. B DK 1 EBITDA is ‪1.17 B‬ EUR, and current EBITDA margin is 32.19%. See more stats in COLOPLAST NAM. B DK 1 financial statements.
Like other stocks, CBHD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COLOPLAST NAM. B DK 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COLOPLAST NAM. B DK 1 technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COLOPLAST NAM. B DK 1 stock shows the sell signal. See more of COLOPLAST NAM. B DK 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.